Carl Dambkowski has an estimated net worth of $30 Million. This is based on reported shares across multiple companies, which include Apogee Therapeutics, Inc., and Oruka Therapeutics, Inc..

2026 was Carl Dambkowski's most active year for acquiring shares with 7 total transactions. Carl Dambkowski's most active month to acquire stocks was the month of December. 2025 was Carl Dambkowski's most active year for disposing of shares, totalling 27 transactions. Carl Dambkowski's most active month to dispose stocks was the month of December. 2026 saw Carl Dambkowski paying a total of $697,801.50 for 230,698 shares, this is the most they've acquired in one year. In 2026 Carl Dambkowski cashed out on 71,225 shares for a total of $3,137,700.88, their largest year based on trade value.